Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ABBV-3373 in moderate to severe rheumatoid arthritis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ABBV-3373

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: COMPLETED | Results posted: 2021-07-19